Our findings are consistent with similar studies in metastatic colorectal cancer, which demonstrated that HER2-low metastatic colorectal cancer is similar to HER2-zero colorectal cancer in terms of prognostic value and molecular landscape [23]. The gene discussed is ERBB2; the disease is metastatic colorectal cancer.